Highlights from the plenary session: end-organ damage and repair

被引:0
|
作者
Sellares, Jacobo [1 ,2 ,3 ,4 ]
Prieto-Gonzalez, Sergio [2 ,3 ,5 ]
机构
[1] Hosp Clin Barcelona, Resp Inst, Dept Resp Med, Barcelona, Spain
[2] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
[3] Univ Barcelona, Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Barcelona, Spain
[5] Univ Barcelona, Hosp Clin, Dept Autoimmune Dis, Vasculitis Res Unit, Barcelona, Spain
关键词
fibrosis; organ damage; mortality; giant cell arteritis; aorta; B cells; ANCA-associated vasculitis; glomerulonephritis; macrophage; interstitial lung disease;
D O I
10.1093/rheumatology/keae424
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The plenary session on "End organ damage and repair" at the 21st International Vasculitis Workshop Congress featured two lectures and three studies addressing the pathogenesis, diagnosis, and management of fibrosis in vasculitis. The studies presented at the session demonstrate the importance of cellular interplay in driving inflammation and fibrosis, like the B cell-fibroblast interactions in the aorta of giant cell arteritis patients and the potential fibrotic role of specific infiltrating macrophage subtypes in ANCA-associated glomerulonephritis. Moreover, organ damage, such as the presence of interstitial lung disease in ANCA-associated vasculitis, may impact on long-term outcome, and need a personalized treatment approach.
引用
收藏
页码:i101 / i103
页数:3
相关论文
共 50 条
  • [41] Exploiting Rat Genetics to Investigate Hypertensive End-Organ Damage
    Liu, Xiaoujun
    Bellamy, Christopher O. C.
    Mullins, Linda J.
    Dunbar, Donald
    Mullins, John J.
    LOCAL CARDIAC RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM, SECOND EDITION, 2009, : 51 - +
  • [42] HYPERTENSION STRATEGIES FOR THERAPEUTIC INTERVENTION AND PREVENTION OF END-ORGAN DAMAGE
    HOUSTON, MC
    PRIMARY CARE, 1991, 18 (03): : 713 - 753
  • [43] Angiotensin II, nitric oxide, and end-organ damage in hypertension
    Bataineh, A
    Raij, L
    KIDNEY INTERNATIONAL, 1998, 54 : S14 - S19
  • [44] Highlights from the plenary session: cellular and molecular mechanisms of disease (I)
    Zimmermann, Jonas
    Schreiber, Adrian
    Heeringa, Peter
    te Velde-Keyzer, Charlotte A.
    RHEUMATOLOGY, 2025, 64 : i85 - i87
  • [45] Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome
    Holle, Julia U.
    Vaglio, Augusto
    RHEUMATOLOGY, 2025, 64 : i92 - i97
  • [46] Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension
    Kolman, S. A. M.
    van Sijl, A. M.
    van der Sluijs, F. A.
    van de Ree, M. A.
    JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (02) : 121 - 125
  • [47] Heart transplantation in patients with diabetic end-organ damage before transplantation
    Aleksic, I
    Czer, LSC
    Freimark, D
    Dalichau, H
    Takkenberg, JJM
    Blanche, C
    Nessim, S
    Nusser, P
    Trento, A
    THORACIC AND CARDIOVASCULAR SURGEON, 1996, 44 (06): : 282 - 288
  • [48] Exercise aortic stiffness: reproducibility and relation to end-organ damage in men
    Keith, L. J.
    Rattigan, S.
    Keske, M. A.
    Jose, M.
    Sharman, J. E.
    JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (08) : 516 - 522
  • [49] Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension
    Bianchi, S
    Bigazzi, R
    Nenci, R
    Campese, VM
    JOURNAL OF NEPHROLOGY, 1997, 10 (06) : 325 - 333
  • [50] A new evidence of end-organ damage in the patients with arterial hypertension: Epistaxis?
    Celik, Turgay
    Iyisoy, Atila
    Yuksel, Uygar Cagdas
    Karahatay, Serdar
    Tan, Yalcin
    Isik, Ersoy
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (01) : 105 - 107